BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in C…
$7.88+2.27%
报价 2026-11-13
市值
$99.9M
EV
$108.2M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -97.1%
$7.20$273.00
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BGMBGM Group Ltd. | $99.9M | +2.3% | – | 12.8% | – | – | 81.1x | |
| SIGASIGA Technologies, Inc. | $196.9M | -5.2% | -32.0% | – | – | – | – | |
| DERMJourney Medical Corporation | $122.2M | -1.4% | +31.1% | 68.4% | – | – | – | |
| CRDLCardiol Therapeutics Inc. | $120.7M | -3.8% | – | 0% | – | – | – | |
| OGIOrganigram Global Inc. | $116.8M | -0.6% | – | 39.2% | 2.6x | – | – | |
| ORGOOrganogenesis Holdings Inc. | $105.2M | -16.1% | -44.9% | 62% | – | – | – | |
| CPIXCumberland Pharmaceuticals Inc. | $88.1M | -11.3% | -14.9% | 79% | 1.3x | – | – | |
| ZYBTZhengye Biotechnology Holding Limited | $71.1M | -1.3% | – | 8.3% | – | – | 14.0x | |
| INCRInterCure Ltd. | $49.2M | -4.8% | – | 0.3% | – | – | 14.1x | |
| 同行中位数 | – | – | -23.5% | 39.2% | 2.0x | – | 14.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
电话会纪要摘要
暂无纪要摘要。